MSKCC, New York, NY, USA.
Support Care Cancer. 2011 Apr;19(4):445-54. doi: 10.1007/s00520-010-0834-9. Epub 2010 Mar 5.
To establish a multidisciplinary Cancer Nutrition Rehabilitation Program (CNRP) for the management of the anorexia-cachexia syndrome (ACS) in an Australian cancer center and to evaluate outcomes of 2 months participation in the CNRP METHOD: Patients were eligible if they had significant anorexia/weight loss, identified by their oncologist or the Malnutrition Screening Tool. In the 9 months that funding was available, 54 participants (37 males, 17 females; median age, 62 years) enrolled. They had mainly lung or gastrointestinal cancers, with 67% receiving chemotherapy concomitantly. Baseline assessments of nutrition and physical status were: median weight 62.7 kg, median weight loss 10.2%, median BMI 21.2 kg/m(2), and 78% malnourished according to PG-SGA. Median baseline Karnofsky performance score (KPS) was 70%, with reduced right-hand grip strength (RGHS; median, 27 kg) and endurance (median, 6 min walk test 6MWT 442 m). Patients received individualized nutritional interventions, exercise programs, and symptom management and were followed prospectively for up to 6 months.
Twenty-five (58%) of 41 evaluable CNRP participants attended the 2-month follow-up. Median weight (63.4 kg), KPS (80%), endurance (6MWT 570 m), and strength (RGHS 28 kg) were all improved. Edmonton symptom assessment scores (36 vs 27) and C-reactive protein levels (39 vs 22) fell. Participants were significantly more likely to return for re-evaluation if at baseline they were having anticancer therapy (odds ratio [OR] 4.7, 95% confidence interval [CI] 1.3-16.2) or could walk >420 m in 6 min (OR 21, 95% CI 1.9-227).
A CNRP may be beneficial for patients with advanced cancer and the ACS, but identification of patients who are likely to stay on the program is needed.
在澳大利亚癌症中心建立一个多学科癌症营养康复计划(CNRP),以管理厌食-恶病质综合征(ACS),并评估该计划 2 个月参与的结果。
如果患者的肿瘤医生或营养不良筛查工具(Malnutrition Screening Tool)确定其存在明显的厌食/体重减轻,则符合入组条件。在获得资金的 9 个月期间,有 54 名患者(37 名男性,17 名女性;中位年龄为 62 岁)入组。他们主要患有肺癌或胃肠道癌,其中 67%的患者同时接受化疗。营养和身体状况的基线评估为:中位体重 62.7kg,中位体重减轻 10.2%,中位 BMI 21.2kg/m2,根据 PG-SGA,78%的患者营养不良。中位基线卡诺夫斯基表现评分(KPS)为 70%,右手握力(RGHS;中位数为 27kg)和耐力(6 分钟步行测试 6MWT,中位数为 442m)均降低。患者接受个体化营养干预、运动计划和症状管理,并前瞻性随访长达 6 个月。
41 名可评估 CNRP 参与者中有 25 名(58%)参加了 2 个月的随访。中位体重(63.4kg)、KPS(80%)、耐力(6MWT 570m)和力量(RGHS 28kg)均有所改善。爱德蒙顿症状评估评分(36 分比 27 分)和 C 反应蛋白水平(39 分比 22 分)降低。如果基线时患者正在接受抗癌治疗(优势比[OR]4.7,95%置信区间[CI]1.3-16.2)或 6 分钟内可行走超过 420m(OR 21,95%CI 1.9-227),则患者更有可能再次接受评估。
CNRP 可能对晚期癌症和 ACS 患者有益,但需要确定哪些患者更有可能继续参与该计划。